Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Dysbiosis × Clear all

Phase

Status

Recruiting 4 Completed 4 Unknown 2 Not yet recruiting 1 No longer available 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 67 Neoplasms 59 Prostatic Neoplasms 37 Colorectal Neoplasms 37 Carcinoma, Non-Small-Cell Lung 25 Lung Neoplasms 24 Carcinoma, Hepatocellular 16 Uterine Cervical Neoplasms 15 Stomach Neoplasms 14 Pancreatic Neoplasms 14 Lymphoma, Follicular 13 Hematologic Neoplasms 13 Leukemia, Myeloid, Acute 12 Brain Neoplasms 12 Anxiety Disorders 12 Urinary Bladder Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Colonic Neoplasms 10 Motor Activity 9 Melanoma 9 Esophageal Neoplasms 9 Cholangiocarcinoma 9 Barrett Esophagus 9 Sarcoma 8 Rectal Neoplasms 8 Ovarian Neoplasms 8 Lymphoma 8 Head and Neck Neoplasms 8 Diabetes Mellitus 8 Myasthenia Gravis 7

Interventions

bismuth tripotassium dicitrate 1 Tetracycline 1 Tablets 1 Metronidazole 1 Lacteol 1 Esomeprazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation

Dysbiosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡